Descripción de negocio
Henry Schein, Inc. (NASDAQ:HSIC) is the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners. The Company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites.
Consejo de gestión & Consejo de supervisión
| CEO |
| Stanley M. Bergman |
| Consejo de gestión |
| Ronald N. South, Andrea Albertini, Leigh Benowitz, James P. Breslawski, Trinh Clark, Brad Connett, Michael S. Ettinger, Lorelei McGlynn, Mark E. Mlotek, James Mullins, Kelly Murphy, Christopher Pendergast, Walter Siegel, René Willi |
| Consejo de supervisión |
| Stanley M. Bergman, Mohamad Ali, James P. Breslawski, Deborah Derby, Joseph L. Herring, Kurt P. Kuehn, Philip A. Laskawy, Anne H. Margulies, Mark E. Mlotek, Steven Paladino, Carol Raphael, Scott Serota, Bradley T. Sheares, Reed V. Tuckson |
Datos de la empresa
| Nombre: |
Henry Schein Inc. |
| Dirección: |
135 Duryea Road,Melville, NY 11747, USA |
| Teléfono: |
+1-631-843-5500 |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
www.henryschein.com |
| Industria: |
Healthcare |
| Sector: |
Medical Products |
| Subsector: |
Advanced Medical Devices |
| Fin del año financiero: |
31/12 |
| Acciones de libre circulación: |
- |
| Fecha de OPI: |
03/11/1995 |
Relación con inversores
| Nombre: |
Graham Stanley |
| IR teléfono: |
+1-631-843-5500 |
| IR-fax: |
- |
| IR e-mail: |
investor@henryschein.com
|
